172@29@17@244!~!172@29@0@53!~!|news|business|moneycontrol-research|gland-pharma-ipo-much-more-than-a-heparin-play-subscribe-6089961.html!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false

MARKET NEWS

View More News
English
Specials
Moneycontrol
WEBINAR :Register now for Commodity Ki Paathshala on Edible Oil Segment 2020-21, Nov 10 at 5PM
you are here: HomeNewsBusinessMoneycontrol Research
  
  1
Last Updated Last Updated : Nov 09, 2020 10:39 AM IST | Source: Moneycontrol.com

Gland Pharma IPO: Much more than a Heparin play; subscribe

Gland Pharma's IPO provides an opportunity to take exposure to a steady earnings compounder with strong credentials

Anubhav Sahu

To view the full content of this article, you have to be a Pro:

  • Not a Moneycontrol Pro subscriber yet?

Subscribe to Moneycontrol Pro:

What's included:

  • Ad free experience across Platforms
  • 230+ exclusive stories per month
  • Sharpest Opinions & Actionable Insights
  • Exclusive Research & Expert Technical Analysis
  • Daily Newsletter
  • 20+ Technical Picks every week
  • Recovery Tracker
  • Exclusive webinars on varied topics
  • Weekly wrap up and much more!!!
Subscribe to PRO and get unlimited access to premium content at Rs.33/- per month. Use code SUPERPRO